
TMCI · NASDAQ
Treace Medical Concepts, Inc.
$4.36 +0.20 (+4.81%)
Company overview
Treace Medical Concepts, Inc., an orthopedic medical device company, designs, manufactures, and markets medical devices for foot and ankle surgeons in the United States. It offers the Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with cosmetic and medical improvement. The company also provides the Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, Weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Exchange
- NASDAQ
- Market cap
- $284M
- Employees
- 477
- Headquarters
- Ponte Vedra, FL
- Website
- treace.com
- CEO
- John T. Treace
- Listed
- April 23, 2021
- P/E
- -4.49
- Dividend yield
- 0.00%
Company financials
- Revenue
- $207M
- Gross profit
- $165M
- Operating income
- -$55.7M
- EBITDA
- -$47.1M
- Net income
- -$61M
- EPS
- -$0.97
- Total assets
- $184M
- Total debt
- $13.6M
- Gross margin
- 79.72%
- Net margin
- -29.44%
- Earnings yield
- -22.25%
News